Gabapentin use and a claim for memory loss in Alaska

Alaska presents a unique gabapentin litigation landscape shaped by its remote geography, limited healthcare infrastructure, and elevated chronic pain prevalence among its workforce. The state's economy relies heavily on fishing, oil extraction, and construction — physically demanding industries that produce high rates of chronic musculoskeletal pain. With specialist access severely limited outside Anchorage and Fairbanks, primary care physicians in rural Alaska communities rely heavily on pharmaceutical pain management, driving gabapentin prescribing rates above the national average. Alaska Native communities face compounded risks from both higher chronic pain rates and reduced access to cognitive health monitoring that would detect gabapentin-induced decline.

For the overall process and updates, read the Gabapentin use and a claim for memory loss overview. This page covers the local information available for Alaska.